Cancel
Known information
- Received his PhD in Computer Science from the University of Colorado where he focused on the intersection of AI and cancer genomics
- Developed the founding IP for Arpeggio
- Trained at Merck and Forma Therapeutics
- Awarded Forbes 30-under-30 in 2020
About Arpeggio Bio
Arpeggio Bio, based in Boulder, CO, specializes in drug discovery targeting transcription factors with AI and RNA-sequencing technologies. The company, with a team of 20, collaborates with industry giants like J&J and FORMA, focusing on diseases such as IO-resistant melanoma and rare genetic disorders.
Report inaccurate information
